One small study, however, found that GLP-1 agonists were associated with significantly reduced pain, fatigue, and opioid dependency
Abstract Background Alcohol use disorder (AUD) affects nearly half a billion people globally and is associated with significant physical and psychiatric comorbidities
This unique formulation combines riboflavin, lecithin, and bromelain, each of which plays an essential role in eliminating fat cells
PubMed Central PMCID: PMC7159259
Only through such focused research can GLP-1 RAs be accurately positioned within evidence-based treatment frameworks for inflammatory skin diseases
The glutamate N -methyl-D-aspartate receptor (NMDAR) antagonist ketamine was recently repurposed as a rapidly acting antidepressant, catalysing the vigorous investigation of glutamate-signalling modulators as novel therapeutic agents for depressive disorders